Iron Gate Global Advisors’s PDS Biotechnology PDSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$43.8K Sell
58,373
-12,033
-17% -$6.84K ﹤0.01% 105
2026
Q2
$62K Sell
70,406
-4,616
-6% -$4.9K 0.01% 107
2026
Q1
$45.4K Buy
75,022
+6
+0% +$5 ﹤0.01% 104
2025
Q4
$57.7K Hold
75,016
– – 0.01% 99
2025
Q3
$76.5K Buy
+75,016
New +$88.2K 0.01% 110
2025
Q2
– Sell
-75,016
Closed -$89.3K – 94
2025
Q1
$89.3K Buy
+75,016
New +$107K 0.01% 90
2024
Q4
– Sell
-75,016
Closed -$287K – 95
2024
Q3
$287K Hold
75,016
– – 0.04% 69
2024
Q2
$220K Hold
75,016
– – 0.04% 90
2024
Q1
$295K Hold
75,016
– – 0.05% 78
2023
Q4
$373K Hold
75,016
– – 0.07% 65
2023
Q3
$377K Hold
75,016
– – 0.08% 57
2023
Q2
$377K Hold
75,016
– – 0.08% 61
2023
Q1
$461K Hold
75,016
– – 0.11% 51
2022
Q4
$990K Hold
75,016
– – 0.27% 36
2022
Q3
$223K Buy
+75,016
New +$318K 0.06% 75
2021
Q3
– Sell
-25,239
Closed -$316K – 123
2021
Q2
$316K Buy
+25,239
New +$197K 0.09% 80
2021
Q1
– Sell
-13,192
Closed -$28K – 101
2020
Q4
$28K Hold
13,192
– – 0.01% 92
2020
Q3
$31K Hold
13,192
– – 0.01% 97
2020
Q2
$27K Buy
+13,192
New +$14.7K 0.01% 86
2019
Q4
– Sell
-14,641
Closed -$49K – 81
2019
Q3
$49K Buy
+14,641
New +$85.2K 0.03% 70

Other funds holding PDSB

Iron Gate Global Advisors's PDSB Position: Q3 2026 in Review

Iron Gate Global Advisors reduced its PDS Biotechnology (PDSB) stake by 17% in Q3 2026, selling an estimated $6.84K and leaving 58,373 shares worth $43.8K. The position accounts for ﹤0.01% of the portfolio, ranked #105.

Iron Gate Global Advisors first reported a position in PDSB in Q3 2019 and has held it in 20 quarters since. The position peaked at $990K in Q4 2022. 60 funds tracked by Wall St. Rank hold PDSB as of Q3 2026.

  • Iron Gate Global Advisors held 58,373 shares of PDS Biotechnology worth $43.8K as of Q3 2026.
  • Iron Gate Global Advisors sold 12,033 PDS Biotechnology shares in Q3 2026, an estimated $6.84K.
  • PDS Biotechnology made up ﹤0.01% of Iron Gate Global Advisors's portfolio in Q3 2026, its #105 holding.
  • Iron Gate Global Advisors first reported a position in PDS Biotechnology in Q3 2019 and has held it in 20 quarters since.
  • Iron Gate Global Advisors's PDS Biotechnology position peaked at $990K in Q4 2022.
  • 60 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2026.

Based on Iron Gate Global Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.